TY - JOUR
T1 - Real-world assessment of physical activity in glaucoma using an accelerometer
AU - Ramulu, Pradeep Y.
AU - Maul, Eugenio
AU - Hochberg, Chad
AU - Chan, Emilie S.
AU - Ferrucci, Luigi
AU - Friedman, David S
N1 - Funding Information:
Supported in part by the Dennis W. Jahnigen Memorial Award, the American Geriatrics Society, New York, NY; the National Institutes of Health , Bethesda, Maryland (grant no.: EY018595 ); the Robert and Helen Schaub Special Scholar Award, Research to Prevent Blindness, New York, New York; and the Intramural Research Program of the National Institute of Aging, National Institutes of Health. All funding organizations had no role in the design or conduct of this research.
PY - 2012/6
Y1 - 2012/6
N2 - Objective: To determine the association between glaucomatous visual field (VF) loss and the amount of physical activity and walking in normal life. Design: Prospective, observational study. Participants: Glaucoma suspects without significant VF or visual acuity loss (controls) and glaucoma subjects with bilateral VF loss between 60 and 80 years of age. Methods: Participants wore an accelerometer over 7 days of normal activity. Main Outcome Measures: Daily minutes of moderate or vigorous physical activity (MVPA) was the primary measure. Steps per day was a secondary measure. Results: Fifty-eight controls and 83 glaucoma subjects provided sufficient study days for analysis. Control and glaucoma subjects were similar in age, race, gender, employment status, cognitive ability, and comorbid illness (P>0.1 for all). Better-eye VF mean deviation (MD) averaged 0.0 decibels (dB) in controls and -11.1 dB in glaucoma subjects. The median control subject engaged in 16.1 minutes of MVPA daily and walked 5891 steps/day, as compared with 12.9 minutes of MVPA daily (P = 0.25) and 5004 steps/day (P = 0.05) for the median glaucoma subject. In multivariate models, glaucoma was associated with 21% less MVPA (95% confidence interval [CI], -53% to 32%; P = 0.37) and 12% fewer steps per day (95% CI, -22% to 9%; P = 0.21) than controls, although differences were not statistically significant. There was a significant dose response relating VF loss to decreased activity, with each 5 dB decrement in the better-eye VF associated with 17% less MVPA (95% CI, -30% to -2%; P = 0.03) and 10% fewer steps per day (95% CI, -16% to -5%; P = 0.001). Glaucoma subjects in the most severe tertile of VF damage (better-eye VF MD worse than -13.5 dB) engaged in 66% less MVPA than controls (95% CI, -82% to -37%; P = 0.001) and took 31% fewer steps per day (95% CI, -44% to -15%; P = 0.001). Other significant predictors of decreased physical activity included older age, comorbid illness, depressive symptoms, and higher body mass index. Conclusions: Overall, no significant difference in physical activity was found between individuals with and without glaucoma, although substantial reductions in physical activity and walking were noted with greater levels of VF loss. Further study is needed to characterize better the relationship between glaucoma and physical activity. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
AB - Objective: To determine the association between glaucomatous visual field (VF) loss and the amount of physical activity and walking in normal life. Design: Prospective, observational study. Participants: Glaucoma suspects without significant VF or visual acuity loss (controls) and glaucoma subjects with bilateral VF loss between 60 and 80 years of age. Methods: Participants wore an accelerometer over 7 days of normal activity. Main Outcome Measures: Daily minutes of moderate or vigorous physical activity (MVPA) was the primary measure. Steps per day was a secondary measure. Results: Fifty-eight controls and 83 glaucoma subjects provided sufficient study days for analysis. Control and glaucoma subjects were similar in age, race, gender, employment status, cognitive ability, and comorbid illness (P>0.1 for all). Better-eye VF mean deviation (MD) averaged 0.0 decibels (dB) in controls and -11.1 dB in glaucoma subjects. The median control subject engaged in 16.1 minutes of MVPA daily and walked 5891 steps/day, as compared with 12.9 minutes of MVPA daily (P = 0.25) and 5004 steps/day (P = 0.05) for the median glaucoma subject. In multivariate models, glaucoma was associated with 21% less MVPA (95% confidence interval [CI], -53% to 32%; P = 0.37) and 12% fewer steps per day (95% CI, -22% to 9%; P = 0.21) than controls, although differences were not statistically significant. There was a significant dose response relating VF loss to decreased activity, with each 5 dB decrement in the better-eye VF associated with 17% less MVPA (95% CI, -30% to -2%; P = 0.03) and 10% fewer steps per day (95% CI, -16% to -5%; P = 0.001). Glaucoma subjects in the most severe tertile of VF damage (better-eye VF MD worse than -13.5 dB) engaged in 66% less MVPA than controls (95% CI, -82% to -37%; P = 0.001) and took 31% fewer steps per day (95% CI, -44% to -15%; P = 0.001). Other significant predictors of decreased physical activity included older age, comorbid illness, depressive symptoms, and higher body mass index. Conclusions: Overall, no significant difference in physical activity was found between individuals with and without glaucoma, although substantial reductions in physical activity and walking were noted with greater levels of VF loss. Further study is needed to characterize better the relationship between glaucoma and physical activity. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
UR - http://www.scopus.com/inward/record.url?scp=84861912811&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84861912811&partnerID=8YFLogxK
U2 - 10.1016/j.ophtha.2012.01.013
DO - 10.1016/j.ophtha.2012.01.013
M3 - Article
C2 - 22386950
AN - SCOPUS:84861912811
SN - 0161-6420
VL - 119
SP - 1159
EP - 1166
JO - Ophthalmology
JF - Ophthalmology
IS - 6
ER -